Vaccine Readiness in People Who Use Substances In Community STI Clinics and Substance Use Intervention or Harm Reduction Programs In Eight Higher HIV Incidence Southeastern Cities

Research is needed to determine prospects for COVID-19 vaccine uptake among people living in higher prevalence communities, hit hard by serial surges, and enacting tenuous policies for COVID-19 mask use, social distancing, and business and social gathering restrictions. Such research is especially crucial for devising strategies to promote vaccine uptake among disenfranchised people of color, who are often limited by disparities due to lower resources and higher mistrust for adopting health care innovations.

CTN Protocol ID: 

Principal Investigator(s)

Susan Tross, Ph.D

Associate Professor
New York State Psychiatric Institute
Clinical Psychology in Psychiatry

1051 Riverside Drive
Unit 15
New York, NY 10032
United States

Mary Hatch-Maillette, Ph.D.

Associate Professor
University of Washington
Department of Psychiatry & Behavioral Sciences
Alcohol & Drug Abuse Institute

1107 NE 45th Street
Suite 120
Seattle, WA 98105-4631
United States